Correlation Between Century Therapeutics and ADTRAN

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and ADTRAN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and ADTRAN into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and ADTRAN Inc, you can compare the effects of market volatilities on Century Therapeutics and ADTRAN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of ADTRAN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and ADTRAN.

Diversification Opportunities for Century Therapeutics and ADTRAN

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Century and ADTRAN is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and ADTRAN Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ADTRAN Inc and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with ADTRAN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ADTRAN Inc has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and ADTRAN go up and down completely randomly.

Pair Corralation between Century Therapeutics and ADTRAN

Given the investment horizon of 90 days Century Therapeutics is expected to under-perform the ADTRAN. In addition to that, Century Therapeutics is 2.51 times more volatile than ADTRAN Inc. It trades about -0.03 of its total potential returns per unit of risk. ADTRAN Inc is currently generating about 0.17 per unit of volatility. If you would invest  773.00  in ADTRAN Inc on September 18, 2024 and sell it today you would earn a total of  67.00  from holding ADTRAN Inc or generate 8.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Century Therapeutics  vs.  ADTRAN Inc

 Performance 
       Timeline  
Century Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Century Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
ADTRAN Inc 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in ADTRAN Inc are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, ADTRAN displayed solid returns over the last few months and may actually be approaching a breakup point.

Century Therapeutics and ADTRAN Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Century Therapeutics and ADTRAN

The main advantage of trading using opposite Century Therapeutics and ADTRAN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, ADTRAN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADTRAN will offset losses from the drop in ADTRAN's long position.
The idea behind Century Therapeutics and ADTRAN Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules